Professor files complaint of scientific misconduct over allegation of ghostwritingBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4458 (Published 13 July 2011) Cite this as: BMJ 2011;343:d4458
- Bob Roehr
- 1Washington, DC
A complaint of scientific misconduct has been filed with the US Office of Research Integrity regarding a ghostwritten paper on paroxetine (marketed as Paxil), published in 2001 in the American Journal of Psychiatry.
In the complaint Jay Amsterdam, a professor of psychiatry at the University of Pennsylvania and co-principal investigator of the paroxetine study 352 for bipolar depression, claims that he was “excluded from the final data review, analysis, and publication.”
Professor Amsterdam’s lawyer wrote in a letter to the university’s president, Amy Gutmann, “It is my client’s belief that the data from his study was effectively stolen from him, manipulated and used in a ghostwritten article . . . in order to advance a marketing scheme by GlaxoSmithKline to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial